Sweden· SE-20150822000017
Luxera 160 mg/g Kräm
A medicinal product containing methyl aminolevulinate, registered in Sweden by Galderma Nordic AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Methyl Aminolevulinate
- Manufacturer
- Galderma Nordic AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20150822000017
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Methyl aminolevulinate in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandLuxeraGalderma Nordic AB
- SpainMETVIX 160 mg/g CREMALaboratorios Galderma S.A.
- IrelandMetvix 160 mg/g creamGalderma International
- IcelandMetvixGalderma Nordic AB*
- NorwayMetvixGalderma Nordic AB
- GermanyLuxermGalderma Laboratorium Gmbh
- United StatesKRX Aesthetics PD-13 TherapyBY KIN AESTHETICS LLC
- BelgiumMetvix 160 mg/gGalderma Benelux
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Luxerm, Metvix
- Belgium · Metvix
- Germany · Luxerm, Metvix
- Denmark · Metvix
- Spain · Metvix
- Finland · Metvix
- France · Metvixia
- United Kingdom (Northern Ireland) · Metvix
- Greece · Metvix
- Ireland · Metvix
- Iceland · Metvix
- Italy · Metvix
- Luxembourg · Metvix
- Malta · Metvix
- Netherlands · Metvix
- Norway · Metvix
- Portugal · Metvix
- Slovakia · Metvix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f37d8533-bf78-4f1b-a5ee-78f156a16990 GET /v1/drugs/f37d8533-bf78-4f1b-a5ee-78f156a16990?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL",
"SmPC",
"PAR",
"sPAR"
],
"se_npl_id": "20150822000017",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20150822000017",
"product_doc_link": "https://docetp.mpa.se/LMF/Luxera%20cream%20ENG%20SmPC_09001bee807a651f.pdf"
}See everything about methyl aminolevulinate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.